Primary Record
Amikacin impurity A
- In stock
- 5,728 g
- Purity
- 98.4 %
- CAS
- 50725-24-1
Compound Identifiers & Properties
- CAS
- 50725-24-1
- PubChem CID
- 3037320
- SMILES
- C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N
- Canonical SMILES
- NCC[C@H](O)C(=O)N[C@H]1C[C@@H](N)[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)[C@@H](O)[C@@H]1O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O
Names & Synonyms
- Amikacin impurity A
- 3-HABA Kanamycin A
- Amikacin EP Impurity A
- 3-HABA Kanamycin A Sulfate
- AC1MI2NI
- RefChem:336574
- BRN 1445424
- 50725-24-1
- DTXSID70964968
- 969DC364WM
- ZINC95876386
- C22-H43-N5-O13
- CID3037320
- IA175581
- LS-146894
- FT-0669093
- 3-(L-4-amino-2-hydroxy-butyryl)kanamycin A
- J3.134.822F
- (2S)-4-amino-N-[(1S,2R,3R,4S,5R)-5-amino-4-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
- Discontinued, Please see H011740, (sulfate salt)
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 3)-(4-amino-2-hydroxybutyryl)-2-deoxy-
- N0001-003441
- 3-(L-4-amino-2-hydroxy-butYHyl)kanamycin A (Amikacin Impurity A)
- (2S)-4-amino-N-[(1S,2R,3R,4S,5R)-5-amino-4-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-{[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide
- (2S)-4-Amino-N-{(1S,2R,3R,4S,5R)-5-amino-4-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-2-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanimidic acid
- (S)-4-amino-N-((1S,2R,3R,4S,5R)-5-amino-4-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide
- (S)-4-amino-N-((1S,2R,3S,4S,5R)-5-amino-4-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4S,5R,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide
- (S)-O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1?6)-O-[6-amino-6-deoxy-a-D-glucopyranosyl-(1?4)]-N3-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine Sulfate; BB-K29 Sulfate; 3-N-[L-(-)-?-Amino-a-hydroxybutyryl]kanamycin A Sulfate; Amikacin EP Impurity A Sulfate
- (S)-O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-->4)]-N3-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine Sulfate
- 4-Amino-N-{5-amino-4-[(3-amino-3-deoxyhexopyranosyl)oxy]-2-[(6-amino-6-deoxyhexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanimidic acid
- 6-O-(3-Amino-3-deoxy-alpha-D-glucopyranosyl)-4-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl)-N -[(S)-4-amino-2-hydroxybutyryl]-2-deoxy-D-streptamine
- 6-O-(3-Amino-3-deoxy-alpha-D-glucopyranosyl)-4-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl)-N3-[(S)-4-amino-2-hydroxybutyryl]-2-deoxy-D-streptamine
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-->4)]-N3-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-->4)]-N3-[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-
- O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-->4)]-N3-[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-D-streptamine